BRCA Founder OutReach (BFOR) Study

Clinical trial NCT03351803 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03351803
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

BRCA1 Mutation BRCA2 Mutation

Start date: 2017-11-10
Primary completion: 2027-05-10
Enrollment: 5412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.